Slowly eroding lesions in multiple sclerosis

Background: At autopsy, 20%–40% of chronic multiple sclerosis (MS) lesions are labeled “slowly expanding” and feature myelin phagocytosis at the lesion edge. As pathological lesion classification relies on a single, terminal time point, the rate of lesion expansion cannot be directly measured. Objective: To study long-term volume changes in individual MS lesions. Methods: Volumes of individual lesions on proton density magnetic resonance imaging (MRI) acquired between 1992 and 2015 were measured in 22 individuals (one lesion per person). After correction for acquisition protocol, a mixed model evaluated lesion volume changes. Results: The mean (standard deviation) lesion volume at baseline was 142 (82) mL, falling to 74 (51) mL after 16 (3) years. All lesions shrank over time. Change in lesion volume did not correlate with change in supratentorial brain volume (p = 0.33). In simulations, the results could be explained by a process of slow radial expansion superimposed on substantially more rapid resorption of damaged tissue. Conclusion: We noted sustained radiological contraction of MS lesions, a surprising result given that fresh myelin breakdown products within chronic active lesions are observed relatively frequently at autopsy. Therefore, the primary pathological process in chronic lesions, even those described as “slowly expanding,” is likely to be tissue loss.

[1]  Istvan Pirko,et al.  Clinical and pathological insights into the dynamic nature of the white matter multiple sclerosis plaque , 2015, Annals of neurology.

[2]  C. Crainiceanu,et al.  Quantification of multiple-sclerosis-related brain atrophy in two heterogeneous MRI datasets using mixed-effects modeling☆ , 2013, NeuroImage: Clinical.

[3]  D. Reich,et al.  The effect of daclizumab on brain atrophy in relapsing-remitting multiple sclerosis. , 2013, Multiple sclerosis and related disorders.

[4]  A. Gass,et al.  Contribution of cortical and white matter lesions to cognitive impairment in multiple sclerosis , 2013, Multiple sclerosis.

[5]  D. Reich,et al.  Multiple sclerosis shrinks intralesional, and enlarges extralesional, brain parenchymal veins , 2013, Neurology.

[6]  M. Calabrese,et al.  Cortical lesion load associates with progression of disability in multiple sclerosis. , 2012, Brain : a journal of neurology.

[7]  J. Parratt,et al.  Oligodendrocytes and the early multiple sclerosis lesion , 2012, Annals of neurology.

[8]  Peter A. Calabresi,et al.  Revisiting Brain Atrophy and Its Relationship to Disability in Multiple Sclerosis , 2012, PloS one.

[9]  Eini Niskanen,et al.  Evolution of global and local grey matter atrophy on serial MRI scans during the progression from MCI to AD. , 2012, Current Alzheimer research.

[10]  M. Calabrese,et al.  Cortical lesions and cognitive impairment in multiple sclerosis , 2010, Neurological Sciences.

[11]  F. Barkhof,et al.  Diffusely Abnormal White Matter in Progressive Multiple Sclerosis: In Vivo Quantitative MR Imaging Characterization and Comparison between Disease Types , 2010, American Journal of Neuroradiology.

[12]  Peter A. Calabresi,et al.  A topology-preserving approach to the segmentation of brain images with multiple sclerosis lesions , 2010, NeuroImage.

[13]  Frederik Barkhof,et al.  Diffusely abnormal white matter in chronic multiple sclerosis: imaging and histopathologic analysis. , 2009, Archives of neurology.

[14]  M. Schlamann,et al.  First Clinical Study on Ultra-High-Field MR Imaging in Patients with Multiple Sclerosis: Comparison of 1.5T and 7T , 2009, American Journal of Neuroradiology.

[15]  H. Lassmann The pathologic substrate of magnetic resonance alterations in multiple sclerosis. , 2008, Neuroimaging clinics of North America.

[16]  DL Collins,et al.  Atrophy in white matter fiber tracts in multiple sclerosis is not dependent on tract length or local white matter lesions , 2008, Multiple sclerosis.

[17]  A. Thompson,et al.  Disability and T2 MRI lesions: a 20-year follow-up of patients with relapse onset of multiple sclerosis. , 2008, Brain : a journal of neurology.

[18]  I. Pirko,et al.  Neuroimaging of demyelination and remyelination models. , 2008, Current topics in microbiology and immunology.

[19]  Hans Lassmann,et al.  The Immunopathology of Multiple Sclerosis: An Overview , 2007, Brain pathology.

[20]  Axel Wismüller,et al.  BMC Neurology BioMed Central , 2006 .

[21]  David H. Miller,et al.  A controlled trial of natalizumab for relapsing multiple sclerosis. , 2003, The New England journal of medicine.

[22]  David H. Miller,et al.  Measurement of atrophy in multiple sclerosis: pathological basis, methodological aspects and clinical relevance. , 2002, Brain : a journal of neurology.

[23]  Massimo Filippi,et al.  Image registration and subtraction to detect active T2 lesions in MS: an interobserver study , 2002, Journal of Neurology.

[24]  Alan J. Thompson,et al.  Disability and lesion load in MS: a reassessment with MS functional composite score and 3D fast FLAIR , 2002, Journal of Neurology.

[25]  E. Cho,et al.  Immunopathology of secondary‐progressive multiple sclerosis , 2001, Annals of neurology.

[26]  J L Ostuni,et al.  Interferon beta-1b and intravenous methylprednisolone promote lesion recovery in multiple sclerosis , 2001, Multiple sclerosis.

[27]  T. Riise,et al.  Disability and prognosis in multiple sclerosis: demographic and clinical variables important for the ability to walk and awarding of disability pension , 2001, Multiple sclerosis.

[28]  N. Mai,et al.  Characteristic MR lesion pattern and correlation of T1 and T2 lesion volume with neurologic and neuropsychological findings in cerebral autosomal dominant arteriopathy with subcortical infarcts and leukoencephalopathy (CADASIL). , 1999, AJNR. American journal of neuroradiology.

[29]  G. Wolswijk Chronic Stage Multiple Sclerosis Lesions Contain a Relatively Quiescent Population of Oligodendrocyte Precursor Cells , 1998, The Journal of Neuroscience.

[30]  A J Thompson,et al.  Multiple sclerosis lesion detection in the brain: A comparison of fast fluid-attenuated inversion recovery and conventional T2-weighted dual spin echo , 1997, Neurology.

[31]  M Filippi,et al.  Comparison of MR pulse sequences in the detection of multiple sclerosis lesions. , 1997, AJNR. American journal of neuroradiology.

[32]  M. Horsfield,et al.  Quantitative assessment of MRI lesion load in monitoring the evolution of multiple sclerosis. , 1995, Brain : a journal of neurology.

[33]  Interferon beta-1b in the treatment of multiple sclerosis: final outcome of the randomized controlled trial. The IFNB Multiple Sclerosis Study Group and The University of British Columbia MS/MRI Analysis Group. , 1995, Neurology.

[34]  E. Cho,et al.  Multiple sclerosis: Remyelination of nascent lesions: Remyelination of nascent lesions , 1993 .

[35]  E. Cho,et al.  Multiple sclerosis: remyelination of nascent lesions. , 1993, Annals of neurology.

[36]  J. Dawson,et al.  The Histology of Disseminated Sclerosis , 1916, Edinburgh Medical Journal.

[37]  J. Dawson,et al.  XVIII.–The Histology of Disseminated Sclerosis , 1916, Transactions of the Royal Society of Edinburgh.